Flash CONtinous glucose monitoring in TRansition to Outpatient: Libre fortype 2 Diabetes Mellitus (CONTROL-DM)
Care Continuum
Care Process & Redesign
Singapore Health Biomedical Congress
National Healthcare Group
31 December 2023
To evaluate the use of Flash Glucose Monitoring (FGM) in improving glycemic control for Type 2 diabetes patients. FGM is a viable alternative to SMBG for managing glycemic control in Type 2 diabetes during transitional care.
Year Submitted: 2023
Published Date: 31 December 2023
Tags: Care Continuum, Care Process ＆ Redesign, Chronic Care, Self Care, Value Based Care, Patient Satisfaction
About this Content
Aims
To evaluate the use of Flash Glucose Monitoring (FGM) in improving glycemic control for Type 2 diabetes patients transitioning from hospital to home.
Background
SMBG compliance is poor due to inconvenience, potentially leading to suboptimal diabetes management.
Methods
Conducted randomized controlled trial with two groups (FGM vs. SMBG) and analyzed HbA1c and patient satisfaction.
Results
HbA1c improved significantly with FGM (4.9%), showing non-inferiority to SMBG; patients preferred FGM for convenience and utility.
Conclusion
FGM is a viable alternative to SMBG for managing glycemic control in Type 2 diabetes during transitional care.
Lessons Learnt
Patient satisfaction and real-time feedback enhance adherence and glycemic outcomes in transitional care.
Additional Information
SHBC 2023 Bronze Award for Clinical Research.
Keywords
Diabetes, Glucose Monitoring, Transitional Care
Innovators' Details
Innovators' Details
Healthcare Cluster(s) | National Healthcare Group |
Organization(s) Involved | Woodlands Health, Tan Tock Seng Hospital |
Platform(s) | Singapore Health Biomedical Congress |
Healthcare Professional Group(s) | Nursing, Medical, Pharmacy |
Applicable Specialty or Discipline | Endocrinology, Pharmacology |
Project Lead(s) | Huilin Koh |
Project Member(s) | Jaime HX Lin |
Connect with this contributor!
Dr Jaime HX Lin - jaime_lin@wh.com.sg